Women’s health

#GLP-1 #Obesity #Weight loss #Women's health

This week in drug discovery (24-28 March) 

News round-up for 24-28 March by DDW Senior Digital Content Editor Diana Spencer. Weight loss drugs have been making the news this week. As we come to the end of Women’s History Month, two of the reported studies focus on women’s health, specifically the role of weight loss… Read More

#News

Close up of vaccine syringe
#Cancer vaccine #HPV #Immunology / Virology & Vaccines #Oncology #Phase II trial #Women's health

Therapeutic HPV vaccine could eliminate precancerous cervical lesions

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).  Dr Refika Yigit, principal investigator and Oncological Gynaecologist at University… Read More

#Cancer Research #News

Female scientists conducting research on samples
#Biobanking #BioGrad #Women's health

Europe’s first private women’s health research tissue bank opens

BioGrad has opened Europe’s first private women’s health research tissue bank as part of a £25 ($30.7) million investment.  Focused on the collection and storage of menstrual blood, peripheral blood, umbilical cord tissue, and umbilical cord blood, BioGrad is calling on females of all backgrounds aged 13… Read More

#News

#Bill & Melinda Gates Foundation #Export and Investment Fund of Denmark (EIFO) #Financing #Freya Biosciences #Women's health

Over $10.4 million invested in women’s and infant health drug 

Women’s health biotech Freya Biosciences has received a $10.4 million strategic investment from the Bill & Melinda Gates Foundation with $1.4 million additional financing from current investor Export and Investment Fund of Denmark (EIFO).  The funds will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis (BV)… Read More

#Business & Investment #News

Endometrial biopsy
#GSK #Oncology #Scottish Medicines Consortium (SMC) #Women's health

GSK’s endometrial cancer therapy approved in Scotland

The Scottish Medicines Consortium (SMC) has accepted GSK’s dostarlimab as a treatment for adult patients with endometrial cancer when used in combination with platinum-containing chemotherapy. Specifically, dostarlimab will be used for patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer and who are candidates for… Read More

#News #Regulatory

#Antibody drug conjugate (ADC) #Bladder cancer #Breast cancer #Depression #Menopause #Oncology #Psychedelics #Women's health

New DDW Highlights podcast for 27 December 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  There have been some ground-breaking advances in women’s health this week, with new treatments… Read More

#News

#Antibody drug conjugate (ADC) #Bladder cancer #Breast cancer #Depression #Menopause #Oncology #Psychedelics #Women's health

This week in drug discovery (18-22 December) 

News round-up for 18-22 December by DDW Digital Content Editor Diana Spencer. There have been some ground-breaking advances in women’s health this week, with new treatments for hot flushes and pregnancy sickness, and a discovery that could aid in development of treatments for secondary breast cancer. In… Read More

#News

Woman suffering from hot flushes
#Astellas Pharma #European Commission #Menopause #MHRA #Women's health

Novel hot flushes treatment approved in UK and EU

Astellas’ Veoza (fezolinetant) will soon be available to some women in the UK suffering from vasomotor symptoms (VMS) associated with menopause following approval by the Medicines and Healthcare Regulatory Agency (MHRA). Despite VMS, or hot flushes, being a common symptom of menopause, until now, hormone replacement therapy (HRT) was the… Read More

#Editor's Choice #News #Regulatory

Pregnancy sickness
#Pregnancy #University of Cambridge #University of Southern California #Women's health

Scientists discover potential treatment for pregnancy sickness

A new study has shown why seven in 10 women experience nausea and vomiting during pregnancy – and why some women become so sick they need to be admitted to hospital. It is caused by GDF15, a hormone produced by the foetus. The new study suggests… Read More

#News

Ovarian cancer cells
#Cancer research #Cancer vaccine #CureLab Oncology #DNA #Oncology #Women's health

DNA therapy effective against chemo-resistant ovarian cancer

A novel DNA vaccine in combination with chemotherapy has demonstrated promising clinical results against a deadly form of ovarian cancer. The investigational compound Elenagen is an experimental DNA therapy that consists of a circular piece of DNA called a plasmid that includes a gene for a… Read More

#Cancer Research #Editor's Choice #News

#Biomarkers #Endometriosis #Genetics / genomics #Women's health

How biomarkers can help discover new treatments for women’s health

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Dr Steve Gardner, Co-Founder and CEO of PrecisionLife about work the company is doing to improve our understanding of endometriosis.  RA: You’ve recently announced a collaboration with the University of Oxford to access genotype data on women… Read More

#Exclusive Content

#BioInnovation Institute #Pregnancy #Start-ups #Women's health

The start-up disrupting the field of women’s reproductive health

Listen to this article on the DDW Podcast: DDW’s Diana Spencer speaks to Alok Javali, CSO of dawn-bio, a new addition to BioInnovation Institute’s (BII) Venture Lab acceleration programme, about the lack of innovation in women’s reproductive health and the company’s plans to fill the vacuum. Earlier this year, dawn-bio was… Read More

#Exclusive Content #Start-up Zone

Endometriosis
#Endometriosis #Genetics / genomics #Personalised medicine #PrecisionLife #University of Oxford #Women's health

Endometriosis partners to discover personalised treatments

PrecisionLife and the University of Oxford have signed a data access agreement to license the Oxford Endometriosis Gene (OXEGENE) dataset to develop new personalised treatments for endometriosis patients. Endometriosis affects 10% of women globally, but on average it takes over seven years for patients to receive… Read More

#News

#Oncology #Women's health

New fund now open to female breast and gynaecologic cancer investigators 

The AACR has announced a new funding opportunity in collaboration with Victoria’s Secret and Pelotonia.  The fund is for female investigators researching breast and gynaecologic cancers that focus on prevention, detection, diagnostic, and treatment innovations for breast and gynaecologic cancers and advancing outcomes for cancer health disparities. Read More

#News

Woman talking to a doctor
#BioInnovation Institute #Collaboration #Ferring Pharmaceuticals #Partnership #Start-ups #Women's health

Partners accelerate innovation in underserved women’s health

BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals have expanded their collaboration with the objective to accelerate world-class life science innovation within women’s health. New activities will include supporting BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine. Read More

#News